About Clozex
Clozex is a company based in Wellesley (United States) founded in 2003 by Michael Lebner. Clozex has raised $4.48 million across 3 funding rounds. Clozex offers products and services including Clozex Closures and Clozex Application Training. Clozex operates in a competitive market with competitors including Cohera Medical, Neomend, GATT Technologies BV, Sealonix and OptMed, among others.
- Headquarter Wellesley, United States
- Founders Michael Lebner
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Clozex Medical, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.48 M (USD)
in 3 rounds
-
Latest Funding Round
$3 M (USD), Debt – Conventional
Nov 01, 2023
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Clozex
Clozex offers a comprehensive portfolio of products and services, including Clozex Closures and Clozex Application Training.
Non-invasive solutions for closing surgical and laceration wounds securely.
Guides on proper application of skin closure devices for users.
People of Clozex
Unlock access to complete
Unlock access to complete
Funding Insights of Clozex
Clozex has successfully raised a total of $4.48M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $3 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Debt – Conventional — $3.0M
-
First Round
First Round
(12 Jun 2019)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2023 | Amount | Debt – Conventional - Clozex | Valuation |
investors |
|
| Feb, 2021 | Amount | Debt – Conventional - Clozex | Valuation |
investors |
|
| Jun, 2019 | Amount | Series A - Clozex | Valuation |
investors |
|
Investments & Acquisitions by Clozex
Financial Statements - Clozex
Clozex Comparisons
Competitors of Clozex
Clozex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cohera Medical, Neomend, GATT Technologies BV, Sealonix and OptMed, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Develops innovative surgical adhesives and sealants for medical use.
|
|
| domain | founded_year | HQ Location |
Provider of air leak sealant for thoracic surgery
|
|
| domain | founded_year | HQ Location |
Polymer-based adhesive tissue tape is developed for surgical sealants.
|
|
| domain | founded_year | HQ Location |
Developer of hemostatic sealants for surgeries
|
|
| domain | founded_year | HQ Location |
Biocompatible polymers and genitourinary therapeutics are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Biomaterials for surgery and wound repair are developed.
|
Frequently Asked Questions about Clozex
Clozex was founded in 2003 and raised its 1st funding round 16 years after it was founded.
Clozex is headquartered in Wellesley, United States. It is registered at Wellesley, Massachusetts, United States.
Clozex is a funded company, having raised a total of $4.48M across 3 funding rounds to date. The company's 1st funding round was a Series A of $4.48M, raised on Jun 12, 2019.
Clozex Medical develops wound closure products. The flagship product is called Clozex Closures, made of interlaced film to align and close the wound non-invasively without the use of sutures or staples. The solution is used in the fields of dermatology, orthopedics, cardiothoracic surgery, plastic surgery, emergency medicine and urgent care.
Clozex's top competitors include Neomend, OptMed and GATT Technologies BV.
Clozex offers Clozex Closures and Clozex Application Training.